Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Pliant closes $62mm Series B round

Executive Summary

Pliant Therapeutics Inc. (therapies for fibrotic disorders) raised $62mm in its Series B financing led by Cowen Healthcare Investments, which adds a board member and was joined by other first-tine backers Eventide Asset Management, Schroder Adveq, Menlo Ventures, SCubed Capital, Agent Capital, and undisclosed institutional investors. The company will use the proceeds to commence proof-of-concept trials in idiopathic pulmonary fibrosis and primary sclerosing cholangitis, and for early-stage pipeline development.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies